Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genome Mining Technique Furthers Biologic Discovery

By LabMedica International staff writers
Posted on 26 Oct 2011
A newly developed method for microscopically extracting, or “mining,” data from genomes could represent a considerable boost in the search for new therapeutic drugs and improve the understanding of basic functions such as how cells communicate with one another. More...


Analyzing marine and terrestrial samples obtained from Alaska to San Diego’s La Jolla Cove, a research technique jointly created by scientists from the University of California San Diego (UCSD) Scripps Institution of Oceanography (La Jolla, USA) and Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD (CA, USA) and their colleagues taps powerful laboratory instruments to trace promising chemical compounds back to their genomic roots. The study’s findings were published the October 9, 2011, online publication of the journal Nature Chemical Biology.

Graduate student Roland Kersten developed a technique that utilizes mass spectrometry, a mass-analyzing application that decodes the composition and size of molecules, to reveal core structural features of genomes. “With only very small amounts of crude sample material, the mass spectrometer is able to fragment the unknown peptide into individual amino acid building blocks, so we can then map those to the genome level,” said Dr. Kersten, who works jointly in Dr. Pieter Dorrestein’s laboratory at the School of Pharmacy and Dr. Brad Moore’s lab at the Scripps Center for Marine Biotechnology and Biomedicine. “That provides us information about how to reassemble the molecule.”
Knowing such details through this genomic mining approach gives scientists a way to connect the natural chemicals generated by organisms back to the enzymes that construct them. These biosynthetic pathways are considered very valuable data in the search for new pharmaceuticals to treat diseases.

Using the new method, the scientists have already discovered two new classes of peptides, compounds comprised of amino acids that serve in functions ranging from communication to protection. “This represents a paradigm shift in the way that natural products are discovered and characterized, and it’s fundamentally different than what’s been practiced for the past decades in this field,” said Dr. Moore, a professor at Scripps and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD. “This has the capability of really changing the way natural products, or simply chemicals, are discovered in nature.”

The researchers are working on ways to automate the process to analyze biological samples faster. They believe the new technique will streamline the discovery of promising natural products. “We’re trying to bring up the speed of discovery in chemistry,” said Dr. Moore. “There’s a huge amount of information that’s out there and we are only scratching the surface-we’d like to dig a little deeper.”

“My UC San Diego colleague Bill Gerwick often states that natural products are a part of central dogma following DNA, RNA and proteins,” said Dr. Dorrestein. “I agree with Bill, natural products and related chemistries control biology yet these molecules are difficult to characterize. The tools for characterizing the molecules that control biology have not kept pace with modern science. The thought process introduced in this manuscript provides the foundation for finally bringing the fourth branch of central dogma into the realm of modern life sciences.”

Related Links:
Scripps Institution of Oceanography
Skaggs School of Pharmacy and Pharmaceutical Sciences


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.